Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_assertion type Assertion NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_head.
- NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_assertion description "[Recent data show that miR-155 is expressed in situ by both malignant and non-malignant T cells, induced via the STAT5 signal pathway and IL-2Rbeta/gamma cytokines, and thus suggest the importance of miR-155 in malignant proliferation, clinical diagnosis, and prognosis in CTCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_provenance.
- NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_assertion evidence source_evidence_literature NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_provenance.
- NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_assertion SIO_000772 24106870 NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_provenance.
- NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_assertion wasDerivedFrom befree-2016 NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_provenance.
- NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_assertion wasGeneratedBy ECO_0000203 NP1117470.RAImW8QuoPFaYezSYan3oFWMS1DB_C2jgAG4L4TtyZeG4130_provenance.